IMATINIB FORMULATIONS
Aspects of the present application relate to pharmaceutical formulations comprising imatinib or its salts, isomers, racemates, enantiomers, hydrates, solvates, metabolites, and polymorphs, and mixtures thereof. Further aspects relate to processes for preparing pharmaceutical formulations comprising...
Gespeichert in:
Hauptverfasser: | , , , , , |
---|---|
Format: | Patent |
Sprache: | eng ; fre |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | BHISE, RAHUL MALLADI, MADHUSUDAN BISWAS, MOUMITA KOTA, RAMESH KONATHAM, SURESH VURE, PRASAD |
description | Aspects of the present application relate to pharmaceutical formulations comprising imatinib or its salts, isomers, racemates, enantiomers, hydrates, solvates, metabolites, and polymorphs, and mixtures thereof. Further aspects relate to processes for preparing pharmaceutical formulations comprising imatinib or its salts, together with at least one pharmaceutically acceptable excipient.
L'invention concerne, dans certains aspects, des formulations pharmaceutiques comprenant l'imatinib ou ses sels, isomères, racémates, énantiomères, hydrates, solvates, métabolites, polymorphes, et leurs mélanges. D'autres aspects concernent des procédés de préparation de formulations pharmaceutiques comprenant l'imatinib ou ses sels, ainsi qu'au moins un excipient pharmaceutiquement acceptable. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2013008253A2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2013008253A2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2013008253A23</originalsourceid><addsrcrecordid>eNrjZBD19HUM8fTzdFJw8w_yDfUBcvz9gnkYWNMSc4pTeaE0N4Oym2uIs4duakF-fGpxQWJyal5qSXy4v5GBobGBgYWRqbGjkTFxqgAjIR_u</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>IMATINIB FORMULATIONS</title><source>esp@cenet</source><creator>BHISE, RAHUL ; MALLADI, MADHUSUDAN ; BISWAS, MOUMITA ; KOTA, RAMESH ; KONATHAM, SURESH ; VURE, PRASAD</creator><creatorcontrib>BHISE, RAHUL ; MALLADI, MADHUSUDAN ; BISWAS, MOUMITA ; KOTA, RAMESH ; KONATHAM, SURESH ; VURE, PRASAD</creatorcontrib><description>Aspects of the present application relate to pharmaceutical formulations comprising imatinib or its salts, isomers, racemates, enantiomers, hydrates, solvates, metabolites, and polymorphs, and mixtures thereof. Further aspects relate to processes for preparing pharmaceutical formulations comprising imatinib or its salts, together with at least one pharmaceutically acceptable excipient.
L'invention concerne, dans certains aspects, des formulations pharmaceutiques comprenant l'imatinib ou ses sels, isomères, racémates, énantiomères, hydrates, solvates, métabolites, polymorphes, et leurs mélanges. D'autres aspects concernent des procédés de préparation de formulations pharmaceutiques comprenant l'imatinib ou ses sels, ainsi qu'au moins un excipient pharmaceutiquement acceptable.</description><language>eng ; fre</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2013</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20130117&DB=EPODOC&CC=WO&NR=2013008253A2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20130117&DB=EPODOC&CC=WO&NR=2013008253A2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>BHISE, RAHUL</creatorcontrib><creatorcontrib>MALLADI, MADHUSUDAN</creatorcontrib><creatorcontrib>BISWAS, MOUMITA</creatorcontrib><creatorcontrib>KOTA, RAMESH</creatorcontrib><creatorcontrib>KONATHAM, SURESH</creatorcontrib><creatorcontrib>VURE, PRASAD</creatorcontrib><title>IMATINIB FORMULATIONS</title><description>Aspects of the present application relate to pharmaceutical formulations comprising imatinib or its salts, isomers, racemates, enantiomers, hydrates, solvates, metabolites, and polymorphs, and mixtures thereof. Further aspects relate to processes for preparing pharmaceutical formulations comprising imatinib or its salts, together with at least one pharmaceutically acceptable excipient.
L'invention concerne, dans certains aspects, des formulations pharmaceutiques comprenant l'imatinib ou ses sels, isomères, racémates, énantiomères, hydrates, solvates, métabolites, polymorphes, et leurs mélanges. D'autres aspects concernent des procédés de préparation de formulations pharmaceutiques comprenant l'imatinib ou ses sels, ainsi qu'au moins un excipient pharmaceutiquement acceptable.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2013</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZBD19HUM8fTzdFJw8w_yDfUBcvz9gnkYWNMSc4pTeaE0N4Oym2uIs4duakF-fGpxQWJyal5qSXy4v5GBobGBgYWRqbGjkTFxqgAjIR_u</recordid><startdate>20130117</startdate><enddate>20130117</enddate><creator>BHISE, RAHUL</creator><creator>MALLADI, MADHUSUDAN</creator><creator>BISWAS, MOUMITA</creator><creator>KOTA, RAMESH</creator><creator>KONATHAM, SURESH</creator><creator>VURE, PRASAD</creator><scope>EVB</scope></search><sort><creationdate>20130117</creationdate><title>IMATINIB FORMULATIONS</title><author>BHISE, RAHUL ; MALLADI, MADHUSUDAN ; BISWAS, MOUMITA ; KOTA, RAMESH ; KONATHAM, SURESH ; VURE, PRASAD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2013008253A23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2013</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>BHISE, RAHUL</creatorcontrib><creatorcontrib>MALLADI, MADHUSUDAN</creatorcontrib><creatorcontrib>BISWAS, MOUMITA</creatorcontrib><creatorcontrib>KOTA, RAMESH</creatorcontrib><creatorcontrib>KONATHAM, SURESH</creatorcontrib><creatorcontrib>VURE, PRASAD</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>BHISE, RAHUL</au><au>MALLADI, MADHUSUDAN</au><au>BISWAS, MOUMITA</au><au>KOTA, RAMESH</au><au>KONATHAM, SURESH</au><au>VURE, PRASAD</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>IMATINIB FORMULATIONS</title><date>2013-01-17</date><risdate>2013</risdate><abstract>Aspects of the present application relate to pharmaceutical formulations comprising imatinib or its salts, isomers, racemates, enantiomers, hydrates, solvates, metabolites, and polymorphs, and mixtures thereof. Further aspects relate to processes for preparing pharmaceutical formulations comprising imatinib or its salts, together with at least one pharmaceutically acceptable excipient.
L'invention concerne, dans certains aspects, des formulations pharmaceutiques comprenant l'imatinib ou ses sels, isomères, racémates, énantiomères, hydrates, solvates, métabolites, polymorphes, et leurs mélanges. D'autres aspects concernent des procédés de préparation de formulations pharmaceutiques comprenant l'imatinib ou ses sels, ainsi qu'au moins un excipient pharmaceutiquement acceptable.</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng ; fre |
recordid | cdi_epo_espacenet_WO2013008253A2 |
source | esp@cenet |
subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
title | IMATINIB FORMULATIONS |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T10%3A17%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=BHISE,%20RAHUL&rft.date=2013-01-17&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2013008253A2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |